Search research articles
Contact Us
Filters
Showing results (231-240 of 300) with videos related to
Page
of 30
Sort By:
Annals of Surgical Oncology
|
March 24, 2010
Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010
Lee G Wilke, Karla V Ballman, Linda M McCall, et al.
ACS Nano
|
September 8, 2020
Fast Neutron Imaging with Semiconductor Nanocrystal Scintillators
Kyle M McCall, Kostiantyn Sakhatskyi, Eberhard Lehmann, et al.
The American Journal of Surgical Pathology
|
June 30, 2018
Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings
Shunyou Gong, Genevieve M Crane, Chad M McCall, et al.
Annals of Surgery
|
December 10, 2015
Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance)
Judy C Boughey, Karla V Ballman, Huong T Le-Petross, et al.
Blood Cancer Journal
|
June 20, 2020
CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma
Rena R Xian, Yi Xie, Lisa M Haley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 19, 2025
Central amygdalar PKCδ neurons mediate fentanyl withdrawal
Lisa M Wooldridge, Jacqueline W K Wu, Adrienne Y Jo, et al.
The Lancet. Oncology
|
November 19, 2013
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial
Aman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 12, 2025
A mechanism for MEX-5-driven disassembly of PGL-3/RNA condensates in vitro
Natasha S Lewis, Silja Zedlitz, Hannes Ausserwöger, et al.
Journal of Medicinal Chemistry
|
April 1, 1990
Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma
E J Jacobsen, J M McCall, D E Ayer, et al.
The American Journal of Surgical Pathology
|
February 28, 2015
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms
Olca Basturk, Zhaohai Yang, Laura H Tang, et al.
Page
of 30
Search research articles
Search
Showing results (231-240 of 300) with videos related to
Sort By:
Page
of 30
Annals of Surgical Oncology
|
March 24, 2010
Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010
Lee G Wilke, Karla V Ballman, Linda M McCall, et al.
ACS Nano
|
September 8, 2020
Fast Neutron Imaging with Semiconductor Nanocrystal Scintillators
Kyle M McCall, Kostiantyn Sakhatskyi, Eberhard Lehmann, et al.
The American Journal of Surgical Pathology
|
June 30, 2018
Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings
Shunyou Gong, Genevieve M Crane, Chad M McCall, et al.
Annals of Surgery
|
December 10, 2015
Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance)
Judy C Boughey, Karla V Ballman, Huong T Le-Petross, et al.
Blood Cancer Journal
|
June 20, 2020
CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma
Rena R Xian, Yi Xie, Lisa M Haley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 19, 2025
Central amygdalar PKCδ neurons mediate fentanyl withdrawal
Lisa M Wooldridge, Jacqueline W K Wu, Adrienne Y Jo, et al.
The Lancet. Oncology
|
November 19, 2013
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial
Aman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 12, 2025
A mechanism for MEX-5-driven disassembly of PGL-3/RNA condensates in vitro
Natasha S Lewis, Silja Zedlitz, Hannes Ausserwöger, et al.
Journal of Medicinal Chemistry
|
April 1, 1990
Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma
E J Jacobsen, J M McCall, D E Ayer, et al.
The American Journal of Surgical Pathology
|
February 28, 2015
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms
Olca Basturk, Zhaohai Yang, Laura H Tang, et al.
Page
of 30